Yuqian Li: a graduate student who majors in neuroscience and currently studying at Capital Medical University Xuanwu Hospital, dedicated to cerebrovascular disease (CVD) fields. Are concentrates on researching cerebral arterial thrombosis's validity clinical targets, pathology signal stimulates, and Ischemic stroke hazard inflammation factor's prognosis through manipulation of FCM, NMR, ELISA, etc. By accidentally, from viewing the thesis and lectures, and sort of self-reconstruction acknowledgments about molecular neuroscience, revealed that the differential of Myeloid progenitor cells is complicated yet accumulates in massives immune cell's life routine, guiding not only as an orientation in cells proliferating but as trigger signal in gene regulations too. This inspired our interest in doing relevant research.

Xue Li a master student, currently majoring neurobiology in Xuanwu Hospital of Capital Medical University. My major is the immune mechanism of ischemic stroke. The main research direction is the immune response of immune cells and its regulatory mechanism after ischemic stroke. Therefore, I have a certain understanding of the pathophysiology of neutrophils, lymphocytes, inflammatory factors, and the response of immune cells after ischemic stroke. I especially understand the IL-2 receptor. By reading the relevant literature, I think the IL-2R has great research potential in the field of cerebrovascular disease. Of course, I am also very interested and committed to the research.

Xiaokun Geng MD, associate professor at Neurology of Capital Medical University. In 2012, he completed his visiting scholar works at Wayne State University. In 2022, he received his Ph.D. from Neurology of Capital Medical University. As a director in Department of Neurology of Luhe Hospital, he engaged in neuro- interventional surgery, clinical and animal research on the basis of cerebral ischemia neuroprotection. He presided over 1 National Natural Science Foundation of China Youth Project, 2 National Natural Science Foundation of China General Projects, 1 Beijing Science and Technology Rising Star Program Project, 1 Beijing Municipal Education Commission General Project and 6 Science and Technology Plan of Beijing Tongzhou District General Project. He was invited many times for oral presentations in the American and European International Stroke Conference. In 2009-2012, he won thrice first and twice second prizes of Tongzhou District Science and Technology Progress Award. In 2013, he was awarded Beijing Excellent Talent and Tongzhou Talent Program. In 2016-2017, he was awarded Tongzhou Star Doctor and awarded Capital Top 100 Young Doctors. In 2019, he was awarded Tongzhou Leading Talent and Canal Talent Development Support Program. He serves as invited editor-in-chief of 2 Journals Neurological Research and China Stroke Journal, editorial board member of 3 Journals Neurological Research, Brain Circulation, and Environmental Diseases. He has published more than 70 SCI papers by the first/corresponding author (Progress In Neurology, Neurotherapeutics, Stroke, Aging Dis., J Neuroinflammation, Mol Neurobiol., etc.). He is currently a visiting professor of Wayne State University, the chairman and executive director of the Beijing Neurology Society Youth Committee, the deputy director of the Beijing Neurology Society Interventional Branch Committee, the standing member of the Beijing Medical Doctor Association Neuro- interventional Specialist Association Youth Committee and the Department of Neurology of Capital Medical University Youth Committee.

Haiping Zhao, MD, researcher professor at the Laboratory of Cerebrovascular Diseases of Capital Medical University. In 2009, she received his Ph.D. from Peking Union Medical College. In 2011, she completed postdoctoral work at Peking University Medical School. She entered the Cerebrovascular Disease Laboratory of Xuanwu Hospital, and engaged in research on the basis of cerebral ischemia neuroprotection and translational medicine. She presided over 1 National Natural Science Foundation of China Youth Project, 3 National Natural Science Foundation of China General Projects, 1 Beijing Natural Science Foundation Key Project, 1 Beijing Science and Technology Rising Star Project, and 1 Beijing Science and Technology Rising Star Interdisciplinary Project. In 2013, she won the Young Scholar Award from the International Cerebral Blood Flow and Brain Metabolism Association; in 2015, she won the 2014 Stroke Progress and Innovation Award from the American Stroke Association; in 2017, she participated in and won the first prize of the Ministry of Education's Higher Education Science and Technology Progress Award; in 2019, she participated in the second prize of the Beijing Municipal Science and Technology Progress Award and the second prize of the China Association of Integrative Medicine Science and Technology Progress Award; in 2020, she participated in the second prize of the National Science and Technology Progress Award. prize. She served as editor-in-chief and published 1 book, and served as deputy editor-in-chief and published 3 books. She has published 86 SCI papers, including 43 papers by the first/corresponding author (Stroke, J Cereb Blood Flow Metab, J Neuroinflammation, British journal of pharmacology, etc.). She is currently the editorial board member of the Chinese Journal of Comparative Medicine, the correspondent editorial board member of the Chinese Journal of Laboratory Animals, and the member of the Translational Medicine Professional Committee of the Beijing Neurological Society.

© 2022 Elsevier Ltd. All rights reserved.